ConductScience.org, home

Paper40487592

Neuroprotection induced by protease-activated receptor 2 activation is independent of Gq signalling.

Moudio S and 2 others. Brain Neurosci Adv, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Neuroprotection induced by protease-activated receptor 2 activation is independent of Gq signalling. Papers, record 40487592. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40487592

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neuroprotection induced by protease-activated receptor 2 activation is independent of Gq signalling.
PubMed
Journal
Brain Neurosci Adv
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-06-11
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Moudio SSerge
2Nuthall HNHugh N
3Bushell TJTrevor Jhttps://orcid.org/0000-0003-4145-9670

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137002616Effect of a protease-activated receptor-2 antagonist (GB88) on inflammation-related loss of alveolar bone in periodontal disease.J Periodontal Res2023https://conductscience.org/library/papers/37002616PubMed
227423137Antagonism of the proinflammatory and pronociceptive actions of canonical and biased agonists of protease-activated receptor-2.Br J Pharmacol2016https://conductscience.org/library/papers/27423137PubMed
333120736Targeting of protease activator receptor-2 (PAR-2) antagonist FSLLRY-NH2 as an asthma adjuvant therapy.Medicine (Baltimore)2020https://conductscience.org/library/papers/33120736PubMed
437072694PAR2 activation in the dura causes acute behavioral responses and priming to glyceryl trinitrate in a mouse migraine model.J Headache Pain2023https://conductscience.org/library/papers/37072694PubMed
511746783Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling.Glia2002https://conductscience.org/library/papers/11746783PubMed
622212680Targeting proteinase-activated receptors: therapeutic potential and challenges.Nat Rev Drug Discov2012https://conductscience.org/library/papers/22212680PubMed
79349532Protease-activated receptor-2 (PAR-2) is present in the rat hippocampus and is associated with neurodegeneration.J Neurochem1997https://conductscience.org/library/papers/9349532PubMed
819527794Essential role of mitogen-activated protein kinase pathways in protease activated receptor 2-mediated nitric-oxide production from rat primary astrocytes.Nitric Oxide2009https://conductscience.org/library/papers/19527794PubMed
917911636Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer's disease.J Immunol2007https://conductscience.org/library/papers/17911636PubMed
1039796264A New Strategy in Modulating the Protease-Activated Receptor 2 (Par2) in Autoimmune Diseases.Int J Mol Sci2025https://conductscience.org/library/papers/39796264PubMed
1125982926Altered Expression of Brain Proteinase-Activated Receptor-2, Trypsin-2 and Serpin Proteinase Inhibitors in Parkinson's Disease.J Mol Neurosci2015https://conductscience.org/library/papers/25982926PubMed
1211356985Proteinase-activated receptors.Pharmacol Rev2001https://conductscience.org/library/papers/11356985PubMed
1321366553Indirect modulation of neuronal excitability and synaptic transmission in the hippocampus by activation of proteinase-activated receptor-2.Br J Pharmacol2011https://conductscience.org/library/papers/21366553PubMed
1418768780Identification and characterization of novel small-molecule protease-activated receptor 2 agonists.J Pharmacol Exp Ther2008https://conductscience.org/library/papers/18768780PubMed
1533242065The development of proteinase-activated receptor-2 modulators and the challenges involved.Biochem Soc Trans2020https://conductscience.org/library/papers/33242065PubMed
1628303089Protease Activated Receptor 2 (PAR2) Induces Long-Term Depression in the Hippocampus through Transient Receptor Potential Vanilloid 4 (TRPV4).Front Mol Neurosci2017https://conductscience.org/library/papers/28303089PubMed
1717666044The role of calcium in protease-activated receptor-induced secretion of chemokine GRO/CINC-1 in rat brain astrocytes.J Neurochem2007https://conductscience.org/library/papers/17666044PubMed
1830738184Interleukin-16 inhibits sodium channel function and GluA1 phosphorylation via CD4- and CD9-independent mechanisms to reduce hippocampal neuronal excitability and synaptic activity.Mol Cell Neurosci2019https://conductscience.org/library/papers/30738184PubMed
1938816842Par2-mediated responses in inflammation and regeneration: choosing between repair and damage.Inflamm Regen2024https://conductscience.org/library/papers/38816842PubMed
2027235359Proteinase-activated receptor 2 is involved in the behavioural changes associated with sickness behaviour.J Neuroimmunol2016https://conductscience.org/library/papers/27235359PubMed

See all 41 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
F2RL12150PubTator's text mininghttps://conductscience.org/library/genes/2150

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40487592

GET https://conductscience.org/api/papers/v1/40487592/references?page=2